First trimester phthalate exposure and anogenital distance in newborns

S. H. Swan, S. Sathyanarayana, E. S. Barrett, S. Janssen, F. Liu, Ruby H Nguyen, Bruce B Redmon

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Study Question Is first trimester phthalate exposure associated with anogenital distance (AGD), a biomarker of prenatal androgen exposure, in newborns? Summary Answer Concentrations of diethylhexyl phthalate (DEHP) metabolites in first trimester maternal urine samples are inversely associated with AGD in male, but not female, newborns. What is Known Already AGD is a sexually dimorphic measure reflecting prenatal androgen exposure. Prenatal phthalate exposure has been associated with shorter male AGD in multiple animal studies. Prior human studies, which have been limited by small sample size and imprecise timing of exposure and/or outcome, have reported conflicting results. Study Design, Size, Duration The Infant Development and the Environment Study (TIDES) is a prospective cohort study of pregnant women recruited in prenatal clinics in San Francisco, CA, Minneapolis, MN, Rochester, NY and Seattle, WA in 2010-2012. Participants delivered 787 infants; 753 with complete data are included in this analysis. Participants/Materials, Setting, Methods Any woman over 18 years old who was able to read and write English (or Spanish in CA), who was <13 weeks pregnant, whose pregnancy was not medically threatened and who planned to deliver in a study hospital was eligible to participate. Analyses include all infants whose mothers provided a first trimester urine sample and who were examined at or shortly after birth. Specific gravity (SpG) adjusted concentrations of phthalate metabolites in first trimester urine samples were examined in relation to genital measurements. In boys (N = 366), we obtained two measures of anogenital distance (AGD) (anoscrotal distance, or AGD AS and anopenile distance, AGD AP) as well as penile width (PW). In girls (N = 373), we measured anofourchette distance (AGD AF) and anoclitoral distance (AGD AC). We used multivariable regression models that adjusted for the infant's age at exam, gestational age, weight-for-length Z-score, time of day of urine collection, maternal age and study center. Main Results and The Role of Chance Three metabolites of DEHP were significantly and inversely associated with both measures of boys' AGD. Associations (β 2, 95% confidence interval (CI)) between AGD AS and (log 10) SpG-adjusted phthalate concentrations were: â '1.12 (â '2.16, â '0.07) for mono-2-ethylhexyl phthalate (MEHP), â'1.43, (â '2.49, â '0.38) for mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and â '1.28 (â '2.29, â '0.27) for mono-2-ethyl-5-hydroxyhexyl (MEHHP). Associations were of similar magnitude for AGD AP. Associations were weaker and not statistically significant for PW. No other phthalate metabolites were associated with any genital measurement in boys. No phthalate metabolites were associated with either AGD measure in girls. Limitations, Reasons For Caution Exposure assessment was based on a single first trimester urine sample, which may have introduced exposure misclassification. In addition, significant between-center differences suggest that this measurement is difficult to standardize. Wider Implications of The Findings Our findings are consistent with multiple rodent studies and most human studies which were far smaller. The data we report here suggest that even at current low levels, environmental exposure to DEHP can adversely affect male genital development resulting in reproductive tract changes that may impact reproductive health later in life. These findings have important implications for public policy since most pregnant women are exposed to this ubiquitous chemical. Study Funding/Competing Interest(S) Funding for TIDES was provided by the following grants from the National Institute of Environmental Health Sciences: R01ES016863-04 and R01 ES016863-02S4. The authors report no conflict of interest.

Original languageEnglish (US)
Pages (from-to)963-972
Number of pages10
JournalHuman Reproduction
Volume30
Issue number4
DOIs
StatePublished - Sep 30 2015

Fingerprint

First Pregnancy Trimester
Diethylhexyl Phthalate
Newborn Infant
Urine
Specific Gravity
Child Development
Androgens
Pregnant Women
National Institute of Environmental Health Sciences (U.S.)
Mothers
Conflict of Interest
Urine Specimen Collection
San Francisco
Organized Financing
Reproductive Health
Environmental Exposure
Maternal Age
Public Policy
Sample Size
Gestational Age

Keywords

  • anogenital distance
  • environmental chemicals
  • phthalate syndrome
  • phthalates
  • prenatal development

Cite this

First trimester phthalate exposure and anogenital distance in newborns. / Swan, S. H.; Sathyanarayana, S.; Barrett, E. S.; Janssen, S.; Liu, F.; Nguyen, Ruby H; Redmon, Bruce B.

In: Human Reproduction, Vol. 30, No. 4, 30.09.2015, p. 963-972.

Research output: Contribution to journalArticle

Swan, SH, Sathyanarayana, S, Barrett, ES, Janssen, S, Liu, F, Nguyen, RH & Redmon, BB 2015, 'First trimester phthalate exposure and anogenital distance in newborns', Human Reproduction, vol. 30, no. 4, pp. 963-972. https://doi.org/10.1093/humrep/deu363
Swan SH, Sathyanarayana S, Barrett ES, Janssen S, Liu F, Nguyen RH et al. First trimester phthalate exposure and anogenital distance in newborns. Human Reproduction. 2015 Sep 30;30(4):963-972. https://doi.org/10.1093/humrep/deu363
Swan, S. H. ; Sathyanarayana, S. ; Barrett, E. S. ; Janssen, S. ; Liu, F. ; Nguyen, Ruby H ; Redmon, Bruce B. / First trimester phthalate exposure and anogenital distance in newborns. In: Human Reproduction. 2015 ; Vol. 30, No. 4. pp. 963-972.
@article{0d3b9740b84f41e4b724a569acea3c80,
title = "First trimester phthalate exposure and anogenital distance in newborns",
abstract = "Study Question Is first trimester phthalate exposure associated with anogenital distance (AGD), a biomarker of prenatal androgen exposure, in newborns? Summary Answer Concentrations of diethylhexyl phthalate (DEHP) metabolites in first trimester maternal urine samples are inversely associated with AGD in male, but not female, newborns. What is Known Already AGD is a sexually dimorphic measure reflecting prenatal androgen exposure. Prenatal phthalate exposure has been associated with shorter male AGD in multiple animal studies. Prior human studies, which have been limited by small sample size and imprecise timing of exposure and/or outcome, have reported conflicting results. Study Design, Size, Duration The Infant Development and the Environment Study (TIDES) is a prospective cohort study of pregnant women recruited in prenatal clinics in San Francisco, CA, Minneapolis, MN, Rochester, NY and Seattle, WA in 2010-2012. Participants delivered 787 infants; 753 with complete data are included in this analysis. Participants/Materials, Setting, Methods Any woman over 18 years old who was able to read and write English (or Spanish in CA), who was <13 weeks pregnant, whose pregnancy was not medically threatened and who planned to deliver in a study hospital was eligible to participate. Analyses include all infants whose mothers provided a first trimester urine sample and who were examined at or shortly after birth. Specific gravity (SpG) adjusted concentrations of phthalate metabolites in first trimester urine samples were examined in relation to genital measurements. In boys (N = 366), we obtained two measures of anogenital distance (AGD) (anoscrotal distance, or AGD AS and anopenile distance, AGD AP) as well as penile width (PW). In girls (N = 373), we measured anofourchette distance (AGD AF) and anoclitoral distance (AGD AC). We used multivariable regression models that adjusted for the infant's age at exam, gestational age, weight-for-length Z-score, time of day of urine collection, maternal age and study center. Main Results and The Role of Chance Three metabolites of DEHP were significantly and inversely associated with both measures of boys' AGD. Associations (β 2, 95{\%} confidence interval (CI)) between AGD AS and (log 10) SpG-adjusted phthalate concentrations were: {\^a} '1.12 ({\^a} '2.16, {\^a} '0.07) for mono-2-ethylhexyl phthalate (MEHP), {\^a}'1.43, ({\^a} '2.49, {\^a} '0.38) for mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and {\^a} '1.28 ({\^a} '2.29, {\^a} '0.27) for mono-2-ethyl-5-hydroxyhexyl (MEHHP). Associations were of similar magnitude for AGD AP. Associations were weaker and not statistically significant for PW. No other phthalate metabolites were associated with any genital measurement in boys. No phthalate metabolites were associated with either AGD measure in girls. Limitations, Reasons For Caution Exposure assessment was based on a single first trimester urine sample, which may have introduced exposure misclassification. In addition, significant between-center differences suggest that this measurement is difficult to standardize. Wider Implications of The Findings Our findings are consistent with multiple rodent studies and most human studies which were far smaller. The data we report here suggest that even at current low levels, environmental exposure to DEHP can adversely affect male genital development resulting in reproductive tract changes that may impact reproductive health later in life. These findings have important implications for public policy since most pregnant women are exposed to this ubiquitous chemical. Study Funding/Competing Interest(S) Funding for TIDES was provided by the following grants from the National Institute of Environmental Health Sciences: R01ES016863-04 and R01 ES016863-02S4. The authors report no conflict of interest.",
keywords = "anogenital distance, environmental chemicals, phthalate syndrome, phthalates, prenatal development",
author = "Swan, {S. H.} and S. Sathyanarayana and Barrett, {E. S.} and S. Janssen and F. Liu and Nguyen, {Ruby H} and Redmon, {Bruce B}",
year = "2015",
month = "9",
day = "30",
doi = "10.1093/humrep/deu363",
language = "English (US)",
volume = "30",
pages = "963--972",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - First trimester phthalate exposure and anogenital distance in newborns

AU - Swan, S. H.

AU - Sathyanarayana, S.

AU - Barrett, E. S.

AU - Janssen, S.

AU - Liu, F.

AU - Nguyen, Ruby H

AU - Redmon, Bruce B

PY - 2015/9/30

Y1 - 2015/9/30

N2 - Study Question Is first trimester phthalate exposure associated with anogenital distance (AGD), a biomarker of prenatal androgen exposure, in newborns? Summary Answer Concentrations of diethylhexyl phthalate (DEHP) metabolites in first trimester maternal urine samples are inversely associated with AGD in male, but not female, newborns. What is Known Already AGD is a sexually dimorphic measure reflecting prenatal androgen exposure. Prenatal phthalate exposure has been associated with shorter male AGD in multiple animal studies. Prior human studies, which have been limited by small sample size and imprecise timing of exposure and/or outcome, have reported conflicting results. Study Design, Size, Duration The Infant Development and the Environment Study (TIDES) is a prospective cohort study of pregnant women recruited in prenatal clinics in San Francisco, CA, Minneapolis, MN, Rochester, NY and Seattle, WA in 2010-2012. Participants delivered 787 infants; 753 with complete data are included in this analysis. Participants/Materials, Setting, Methods Any woman over 18 years old who was able to read and write English (or Spanish in CA), who was <13 weeks pregnant, whose pregnancy was not medically threatened and who planned to deliver in a study hospital was eligible to participate. Analyses include all infants whose mothers provided a first trimester urine sample and who were examined at or shortly after birth. Specific gravity (SpG) adjusted concentrations of phthalate metabolites in first trimester urine samples were examined in relation to genital measurements. In boys (N = 366), we obtained two measures of anogenital distance (AGD) (anoscrotal distance, or AGD AS and anopenile distance, AGD AP) as well as penile width (PW). In girls (N = 373), we measured anofourchette distance (AGD AF) and anoclitoral distance (AGD AC). We used multivariable regression models that adjusted for the infant's age at exam, gestational age, weight-for-length Z-score, time of day of urine collection, maternal age and study center. Main Results and The Role of Chance Three metabolites of DEHP were significantly and inversely associated with both measures of boys' AGD. Associations (β 2, 95% confidence interval (CI)) between AGD AS and (log 10) SpG-adjusted phthalate concentrations were: â '1.12 (â '2.16, â '0.07) for mono-2-ethylhexyl phthalate (MEHP), â'1.43, (â '2.49, â '0.38) for mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and â '1.28 (â '2.29, â '0.27) for mono-2-ethyl-5-hydroxyhexyl (MEHHP). Associations were of similar magnitude for AGD AP. Associations were weaker and not statistically significant for PW. No other phthalate metabolites were associated with any genital measurement in boys. No phthalate metabolites were associated with either AGD measure in girls. Limitations, Reasons For Caution Exposure assessment was based on a single first trimester urine sample, which may have introduced exposure misclassification. In addition, significant between-center differences suggest that this measurement is difficult to standardize. Wider Implications of The Findings Our findings are consistent with multiple rodent studies and most human studies which were far smaller. The data we report here suggest that even at current low levels, environmental exposure to DEHP can adversely affect male genital development resulting in reproductive tract changes that may impact reproductive health later in life. These findings have important implications for public policy since most pregnant women are exposed to this ubiquitous chemical. Study Funding/Competing Interest(S) Funding for TIDES was provided by the following grants from the National Institute of Environmental Health Sciences: R01ES016863-04 and R01 ES016863-02S4. The authors report no conflict of interest.

AB - Study Question Is first trimester phthalate exposure associated with anogenital distance (AGD), a biomarker of prenatal androgen exposure, in newborns? Summary Answer Concentrations of diethylhexyl phthalate (DEHP) metabolites in first trimester maternal urine samples are inversely associated with AGD in male, but not female, newborns. What is Known Already AGD is a sexually dimorphic measure reflecting prenatal androgen exposure. Prenatal phthalate exposure has been associated with shorter male AGD in multiple animal studies. Prior human studies, which have been limited by small sample size and imprecise timing of exposure and/or outcome, have reported conflicting results. Study Design, Size, Duration The Infant Development and the Environment Study (TIDES) is a prospective cohort study of pregnant women recruited in prenatal clinics in San Francisco, CA, Minneapolis, MN, Rochester, NY and Seattle, WA in 2010-2012. Participants delivered 787 infants; 753 with complete data are included in this analysis. Participants/Materials, Setting, Methods Any woman over 18 years old who was able to read and write English (or Spanish in CA), who was <13 weeks pregnant, whose pregnancy was not medically threatened and who planned to deliver in a study hospital was eligible to participate. Analyses include all infants whose mothers provided a first trimester urine sample and who were examined at or shortly after birth. Specific gravity (SpG) adjusted concentrations of phthalate metabolites in first trimester urine samples were examined in relation to genital measurements. In boys (N = 366), we obtained two measures of anogenital distance (AGD) (anoscrotal distance, or AGD AS and anopenile distance, AGD AP) as well as penile width (PW). In girls (N = 373), we measured anofourchette distance (AGD AF) and anoclitoral distance (AGD AC). We used multivariable regression models that adjusted for the infant's age at exam, gestational age, weight-for-length Z-score, time of day of urine collection, maternal age and study center. Main Results and The Role of Chance Three metabolites of DEHP were significantly and inversely associated with both measures of boys' AGD. Associations (β 2, 95% confidence interval (CI)) between AGD AS and (log 10) SpG-adjusted phthalate concentrations were: â '1.12 (â '2.16, â '0.07) for mono-2-ethylhexyl phthalate (MEHP), â'1.43, (â '2.49, â '0.38) for mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and â '1.28 (â '2.29, â '0.27) for mono-2-ethyl-5-hydroxyhexyl (MEHHP). Associations were of similar magnitude for AGD AP. Associations were weaker and not statistically significant for PW. No other phthalate metabolites were associated with any genital measurement in boys. No phthalate metabolites were associated with either AGD measure in girls. Limitations, Reasons For Caution Exposure assessment was based on a single first trimester urine sample, which may have introduced exposure misclassification. In addition, significant between-center differences suggest that this measurement is difficult to standardize. Wider Implications of The Findings Our findings are consistent with multiple rodent studies and most human studies which were far smaller. The data we report here suggest that even at current low levels, environmental exposure to DEHP can adversely affect male genital development resulting in reproductive tract changes that may impact reproductive health later in life. These findings have important implications for public policy since most pregnant women are exposed to this ubiquitous chemical. Study Funding/Competing Interest(S) Funding for TIDES was provided by the following grants from the National Institute of Environmental Health Sciences: R01ES016863-04 and R01 ES016863-02S4. The authors report no conflict of interest.

KW - anogenital distance

KW - environmental chemicals

KW - phthalate syndrome

KW - phthalates

KW - prenatal development

UR - http://www.scopus.com/inward/record.url?scp=84926619061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926619061&partnerID=8YFLogxK

U2 - 10.1093/humrep/deu363

DO - 10.1093/humrep/deu363

M3 - Article

VL - 30

SP - 963

EP - 972

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 4

ER -